Why did the FDA warn telehealth firms about GLP‑1 sales? #health

Why did the FDA warn telehealth firms about GLP‑1 sales? #health

Key reasons for the regulatory action Federal regulators sent warning letters to dozens of telehealth and online pharmacies after finding companies marketing and distributing GLP‑1 weight‑loss and diabetes drugs in ways that may violate federal law and safety…

Key reasons for the regulatory action Federal regulators sent warning letters to dozens of telehealth and online pharmacies after finding companies marketing and distributing GLP1 weightloss and dia… [+1842 chars]
Why did the FDA warn telehealth firms about GLP‑1 sales? #health - FHMnews